Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-30

Clinical Trial Update: Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the efficacy and safety of propofol infusion for refractory chronic primary insomnia. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)

Snippet

Sponsor: Life Extension Foundation Inc. | Conditions: Insomnia, Sleep Disorder | Phase 1 | Status: COMPLETED